Sun Pharma gets NSE’s nod to transfer business

25 Mar 2014 Evaluate

Sun Pharmaceutical Industries has received National Stock Exchange’s (NSE) approval to merge ‘specified therapeutic and investment’ business of its subsidiary into itself. As per norms, companies seeking to execute merger or de-merger strategies need to obtain a 'no-objection certificate' from stock exchanges.

In November 2013, the company already received its board’s approval to transfer ‘specified therapeutic and investment’ business, a part of Sun Pharma Global FZE, into itself.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

 

Sun Pharma Inds. Share Price

1631.65 -2.75 (-0.17%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×